Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor α (ESR1) PvuII and XbaI gene polymorphisms

Clinica Chimica Acta

Volumn 380, Issue 1-2, 2007, Pages 157-164

  Molvarec, Attila ^a   Nagy, Bálint ^b   Kovács, Margit ^c   Walentin, Szilvia ^a   Imreh, Éva ^a   Rigó Jr , János ^b   Szalay, János ^a   Füst, George ^c   Prohászka, Zoltán ^c   Karádi, István ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Estrogen receptor; Gene; Haemostasis; Inflammation; Lipoprotein; Polymorphism

Indexed keywords

ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CHOLESTEROL; ESTROGEN RECEPTOR ALPHA; FIBRINOGEN; FOLLITROPIN; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IODINE 125; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN C; PROTEIN S; THROMBIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; AUTOANALYZER; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HORMONE ACTION; HUMAN; IMMUNORADIOMETRIC ASSAY; INFLAMMATION; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; PVUII GENE; REPRODUCTION; XBAI GENE;

ADOLESCENT; ADULT; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ESTROGEN RECEPTOR ALPHA; FEMALE; GENOTYPE; HEMOSTASIS; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33947699808     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.02.005     Document Type: Article

References (48)

1. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
2. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., and Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103 (2001) 423-428
3. Pare G., Krust A., Karas R.H., et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 90 (2002) 1087-1092
4. Kolodgie F.D., Jacob A., Wilson P.S., et al. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol 148 (1996) 969-976
5. Bhalla R.C., Toth K.F., Bhatty R.A., Thompson L.P., and Sharma R.V. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol 272 (1997) H1996-H2003
6. Knopp R.H., and Zhu X. Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab 82 (1997) 3952-3954
7. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
8. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534
9. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289 (2003) 2673-2684
10. Hendrix S.L., Wassertheil-Smoller S., Johnson K.C., et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 113 (2006) 2425-2434
11. Rosendaal F.R. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program (2005) 1-12
12. Vongpatanasin W., Tuncel M., Wang Z., Arbique D., Mehrad B., and Jialal I. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 41 (2003) 1358-1363
13. Parker M.G., Arbuckle N., Dauvois S., Danielian P., and White R. Structure and function of the estrogen receptor. Ann N Y Acad Sci 684 (1993) 119-126
14. Ponglikitmongkol M., Green S., and Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 7 (1988) 3385-3388
15. Lehtimaki T., Kunnas T.A., Mattila K.M., et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med 80 (2002) 176-180
16. Shearman A.M., Cupples L.A., Demissie S., et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290 (2003) 2263-2270
17. Schuit S.C., Oei H.H., Witteman J.C., et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
18. Straczek C., Alhenc-Gelas M., Aubry M.L., and Scarabin P.Y. Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal women. J Thromb Haemost 3 (2005) 1535-1537
19. Lussana F., Faioni E.M., Mavilia C., Bucciarelli P., Brandi M.L., and Cattaneo M. Association of estrogen receptor-alpha gene polymorphisms with venous thrombosis. Haematologica 91 (2006) 279-280
20. Molvarec A., Ver A., Fekete A., et al. Association between estrogen receptor α (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res 30 (2007) 205-211
21. Weel A.E., Uitterlinden A.G., Westendorp I.C., et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84 (1999) 3146-3150
22. van Meurs J.B., Schuit S.C., Weel A.E., et al. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 12 (2003) 1745-1754
23. Fox C.S., Yang Q., Cupples L.A., et al. Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab 90 (2005) 6257-6262
24. Peter I., Shearman A.M., Zucker D.R., et al. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens 23 (2005) 2193-2200
25. Lehtimaki T., Laaksonen R., Mattila K.M., et al. Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men. Eur J Clin Invest 32 (2002) 400-404
26. Soules M.R., Sherman S., Parrott E., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76 (2001) 874-878
27. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
28. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
29. Knopp R.H. Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am J Obstet Gynecol 158 (1988) 1630-1643
30. Ma P.T., Yamamoto T., Goldstein J.L., and Brown M.S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. Proc Natl Acad Sci U S A 83 (1986) 792-796
31. Lamon-Fava S., Ordovas J.M., and Schaefer E.J. Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 19 (1999) 2960-2965
32. Jones D.R., Schmidt R.J., Pickard R.T., Foxworthy P.S., and Eacho P.I. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res 43 (2002) 383-391
33. Matsubara Y., Murata M., Kawano K., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17 (1997) 3006-3012
34. Kikuchi T., Hashimoto N., Kawasaki T., and Uchiyama M. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr 89 (2000) 42-45
35. Bagger Y.Z., Hassager C., Heegaard A.M., and Christiansen C. Vitamin D receptor and estrogen receptor gene polymorphisms in postmenopausal Danish women: no relation to bone markers or serum lipoproteins. Climacteric 3 (2000) 84-91
36. Herrington D.M., Howard T.D., Hawkins G.A., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346 (2002) 967-974
37. Lu H., Higashikata T., Inazu A., et al. Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 22 (2002) 817-823
38. Nordstrom P., Glader C.A., Dahlen G., et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 254 (2003) 140-146
39. Demissie S., Cupples L.A., Shearman A.M., et al. Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis 185 (2006) 210-218
40. Silvestri S., Thomsen A.B., Gozzini A., Bagger Y., Christiansen C., and Brandi M.L. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?. Menopause 13 (2006) 451-461
41. Almeida S., Fiegenbaum M., de Andrade F.M., Osorio-Wender M.C., and Hutz M.H. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy. Maturitas 54 (2006) 119-126
42. Huang Q., Wang T.H., Lu W.S., et al. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J (Engl) 119 (2006) 1794-1801
43. de Maat M.P., Bladbjerg E.M., Kluft C., et al. Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis. Hum Reprod 21 (2006) 1473-1476
44. Alessio AM, Hoehr NF, Siqueira LH, Ozelo MC, de Padua Mansur A, Annichino-Bizzacchi JM. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis. Thromb Res in press, doi:10.1016/j.thromres.2006.10.019.
45. Herrington D.M., Howard T.D., Brosnihan K.B., et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
46. Swartz C.D., Afshari C.A., Yu L., Hall K.E., and Dixon D. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod 11 (2005) 441-450
47. Cai Q., Shu X.O., Jin F., et al. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 12 (2003) 853-859
48. Weiderpass E., Persson I., Melhus H., Wedren S., Kindmark A., and Baron JA. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 21 (2000) 623-627